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LOCAL INJECTIONS OF A PREPARATION OF HYALIJRONIDASE
IN THE TREATMENT OF M[JCINOUS INFILTRATION
OF THE SKIN*t
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The subject of the enzyme hyaluronidase, and the mucopolysaccharide
hyaluronic acid (hyaluronate) which is hydrolyzed by that enzyme, has in recent
years captivated the interest and imagination of physicians and investigators in
different fields of biology and medicine. In a recent conference of the New York
Academy of Sciences, Section of Biology, as many as 36 papers were read dealing
with "The Ground Substance of the Mesenchyme and Hyaluronidase." This
great interest is due to the fact that the subject of hyaluronidase opens a new
approach to fundamental problems in biology and medicine.
The name hyaluronidase was given by Karl Meyer and Palmer in 1934 (1) to an
enzyme which they found in autolysates of a type II pneumococcus, which is
capable of hydrolyzing hyaluronic acid. The hyaluronidase activity was shown
by Chain and Duthie (2) to be similar to the activity of testicular spreading factor
of Duran-Reynals (3). The last-named author has established the presence of
so-called "spreading factors" or "diffusion factors" in bovine testes, factors which
were later detected also in snake venoms, spider and bee venoms and in certain
bacteria. The spreading factors facilitate the passage of living or dead particles
through the cutaneous connective tissue matrix in which the cells and fibers are
embedded. This matrix or ground substance is often denoted as gelatinous
material or a "mucin." This mucinous substance was found by Karl Meyer and
collaborators (4, 5) to contain a mixture of mucopolysaccharides, one of which
they termed "hyaluronic acid."
HYALTJRONIC ACID AND HYALTJRONIDASE IN SKIN
Although the main source of hyaluronidase is bovine testis, Meyer and co-
workers (6) assume that the human skin probably stores most of the hyaluronidase
in the body, although generally in inactive form. They believe that it may
participate in the regulation of the velocity of water and metabolic exchange,
by modifying the viscosity of the connective tissue matrix.
It is now widely accepted that hyaluronidase is identical with the so-called
spreading factor of Duran-Reynals. In the absence of this factor, an indicator
like ink or dye injected intradermally remains localized in one area from which
it spreads at slow rate. Hyaluronidase solution spreads the indicator rapidly.
The rapidity depends on the concentration of the enzyme, and the extent of spread
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depends on the volume of injected solution. This spreading activity of hya-
luronidase is caused by removal of a tissue barrier to fluid diffusion, thought to be
hyaluronate-gel which is present in the ground substance of connective tissue,
and which is depolymerized by the enzyme.
Until recently most of the investigations regarding the presence of hyaluronic
acid and hyaluronidase in the skin dealt with animal skin. Meyer and Chaffee
(5) have isolated hyaluronic acid in great amounts from pig skin. A similar sub-
stance was obtained by Chain and Duthie from rabbit skin. Relatively little
work was done with human skin. Reuter (7) concluded from results of muci-
carmine staining that the normal human skin contains mucin in very small
amounts. It was Watson (8) who proved for the first time by a method originated
by Meyer and Palmer, that the normal human skin contains hyaluronic acid.
It is of great interest to know that the amount of hyaluronic acid in the skin may
possibly be subject to the influence of hormones. For Sprunt and coworkers (9)
found a decrease in the spread of ink in the skin of rabbits following injection of
estrogenic hormone.
CLINICAL USE OF HYALURONIDASE
Different attempts were made to utilize hyaluronidase therapeutically.
Pathologic joints in which the viscosity of the exudate appeared to be increased
were injected with hyaluronidase solution (10), but no permanent improvement
was obtained. Hyaluronidase was successfully used in paracenthesis in mesen-
thelioma of the pleura and peritoneum by facilitating removal of fluid of a honey-
like consistency (11). Kurzrok and coworkers claim to have used it successfully
to induce pregnancy in certain cases of sterility (12) Hechter and coworkers (13)
showed its beneficial effect in hypodermoelysis in 3 patients. For they obtained
by means of hyaluronidase a markedly increased absorption of the fluid. In one
patient with circulatory collapse circulation was restored after ordinary hypoder-
moclysis had failed. Hyaluronidase was successfully used also in the treatment
of ganglia of tendon sheaths (14).
MUCINOTJS INFILTRATION OF THE SKIN
This condition, whether associated with manifestations of thyroid disease or
not, is extremely resistant to treatment. Although several authors (O'Leary (15),
Pillsbury and Stokes (16), Trotter and Eden (17), and E. L. Cohen (18)) state that
in some cases the lesions have a tendency to disappear spontaneously or in response
to thyroid treatment, these and other authors admit that most of the cases, par-
ticularly those of the plaque tJpe located on the tibia, do not respond to any treat-
ment whatsoever.
Already as far back as 1898, Ord (19) who coined the name "myxedema,"
found that the edematous impregnation was due to accumulation of mucin in the
upper connective tissue. He estimated the amount to be 50 times that of normal
skin. Carol (20) found in myxedema a slight reduction of Fehling's solution after
hydrolysis of the mucinous substance with hydrochloric acid. In regard to the
content of hyaluronic acid in this mucinous substance there were only suggestive
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statements made by Trotter and Eden (17) and by Chain and Duthie that hya-
luronic acid may be a constituent of the mucinous substance in localized myxedema.
It was Watson (8), however, and Watson and Pearce (21) who proved by fraction-
ated analysis that myxedematous tissue contains hyaluronic acid and that this
substance was present in much greater quantities than in control samples of skin
from normal people.
As a natural consequence of the above facts one would expect that attempts be
made to use hyaluronidase in the treatment of mucinous infiltration of the skin.
But, as far as we could ascertain, there is no report of such treatment in the litera-
ture to date except a statement suggesting this therapy. This statement was
made by Trotter and Eden (17) who say that "if it could be shown that hyaluroni-
dase caused these swellings to disappear, important information as to their
chemical nature would have been obtained as well as an effective method of treat-
ment." The reason for the fact that no report of such treatment is found in the
literature is probably due in part to the relative rarity of cases of mucinous
infiltration of the skin.
REPORT OF CASES TREATED WITH HYALURONIDASE
Case 1.1 M. G., a man aged 72, registered at the New York Skin and Cancer Unit on
Nov. 3, 1947, for skin lesions which he had noticed 4 months previously. He presented on
the inner aspect of the left thigh two irregularly shaped, well defined, somewhat raised
plaques of gray bluish color, one about 31 inches in diameter, the other somewhat smaller.
These lesions were surrounded by several lentil to pea-sized nodules of the same character.
The plaques had a doughy consistency, and the larger elevations were studded with indi-
vidual pea sized and larger globular nodules which appeared edematous. The eruption did
not cause any subjective symptoms.
The patient appeared in good general health. His past and family history were es-
sentially irrelevant. Routine laboratory examinations, including blood chemistry and
basal metabolism tests, gave normal findings.
A biopsy from the myxedematous lesion was done before the patient received treatment
and the following report was obtained from Dr. Charles Sims: "The epidermis is rather
thin with slightly elongated rete pegs. The collagen of the upper corium presents parenchy-
matous edema with considerable fragmentation of the fibrils. In some areas the latter
take a pinkish red stain and in part show fragmentation and granular degeneration. The
superficial vessels are dilated, their walls edematous and their intima shows fragmented
nuclei. Scattered fibroblasts are present in larger numbers than usual in the upper corium
(hexmatoxylin-eosin stain). Mucin stain reveals in the upper corium fibroblasts which ta/ce a
violaceous color." The pathologic diagnosis was: Mucinous infiltration of the skin.
The patient was treated with injections of hyaluronidase' solution, from December 15,
1947, to March 15, 1948. According to the labeling of the preparation, four turbidity reduc-
ing units (T.R.IJ.) were dissolved' in 10 cc. of saline solution and different amounts injected
'Presented at the Manhattan Dermatological Society in 1947 by Dr. H. Sharlit and at
the Bronx Dermatological Society in November 1947, by Dr. D. Bloom.
'Hyaluronidase was obtained by courtesy of the Schering Corporation of Bloomfield,
New Jersey.
It is necessary to point out that the strength indicated by the label on the hyaluronidase
preparation is not an accurate index of actual hyaluronidase activity at the time of use.
Therefore it is not possible to conclude exactly how much (if any) hyaluronidase was in-
jected at each treatment.
very small amounts of dry substance in the individual ampules dissolved at very
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into multiple sites of the lesions. Injections were given at different intervals; first at
intervals of a few days, then at intervals of a week. Thirteen treatments were given
altogether, the amount of solution injected varying between 3 and 8 cc. Following two
treatments a distinct flattening of the plaques was noted. With the subsequent treatments,
improvement was noted from time to time. But in the last few weeks of treatment no
change in the lesions took place.
On July 26, 1948, several months following the treatment, another biopsy was taken
which showed the same findings as the first.
Case. E. D., a colored woman age 35, registered at the Sydenham Hospital Skin Clinic
on Dec. 5, 1947, complaining of an eruption on both legs of 20 years' duration. She pre-
sented on the anterior aspect of the right leg several raised lesions, 2 inches in diameter each,
roundish in shape, and dough-like in consistency. Two lesions showed a depressed center
and a raised dough-like border. The skin of the left leg showed diffuse thickening above
the external malleolus, and above it, about the level of the lower third of the leg there was
slight depigmentation and scaling.
The patient showed marked exophthalmos and gave a history of a thyroidectomy 20
years previously, following which the lesions on the legs developed and hardly changed
since then.
Routine laboratory examinations of blood and urine gave normal findings. The basal
metabolic rate was plus 5 on one occasion and plus 12 on another. Biopsy from one of the
lesions on the right leg showed the same pathologic structure as in case 1.
From April 9, 1948 to June 28, 1948, eleven treatments with hyaluronidase solution were
given. Four T.R.IJ. were dissolved by shaking in 5 cc. of saline solution of which 3 to 5 cc.
were injected into 2 lesions of the right leg. The injections were given at weekly intervals.
Already following the first injection improvement in the thickness and infiltration of the
lesions was noted. At the conclusion of the series of treatments there was definite flatten-
ing of the lesions. It was noted that the lesions became gradually firmer in consistency
and they offered resistance to the injected fluid. Injections were therefore discontinued.
Although there was marked improvement, the lesions did not flatten out entirely.
COMMENT
We realize that no conclusions can be drawn in this preliminary report and that
these investigations will have to be continued. If we take into consideration the
statement of Chain and Duthie that hyaluronidase solution disintegrates following
shaking, doubt has to be cast on our assumption that the improvement in the
treated cases was due to hyaluronidase, as our liquid had to be shaken at times
in order to facilitate solution. Moreover, as stated, tests by Prose and Weingarten
of the New York Skin and Cancer Unit have shown that the hyaluronidase acti-
vity of the preparation used did not correspond to the labeling, some of the
ampules having no enzyme activity whatsoever. It is therefore possible that our
results may not have been due to hyaluronidase and that repeated injections of
other materials, or even of saline alone given under pressure might possibly lead
to the same results. We intend, therefore, in future cases of mucinous infiltrations,
different rates; occasionally a clear solution was obtained immediately, whereas at times
most of the dry substance remained in suspension, and prolonged shaking appeared un-
avoidable. The manufacturers gave the information that any not readily soluble com-
ponents are "inert by-products." Tests by Prose and Weingarten of our Department have
shown that the preparations were of variable hyaluronidase potency, and that the potency
indicated on the labels was not a true index of activity at time of use.
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to inject control sites with other substances, including saline solution alone. We
intend also to use hyaluronidase in much higher concentrations and in a more
stabilized and accurately doseable form with the hope of achieving still better
results.
In spite of the above reservations, we feel that the submission of this report may
he justified. For it is to our knowledge the first attempt to treat mucinous de-
generation with hyaluronidase. We confidently hope that this report will stimu-
late the further interest of dermatologists in the subject of hyaluronidase and may
possibly lead to its successful use in some dermatologic and other diseases.
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